{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:41:50Z","timestamp":1776872510014,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01202-9","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:49:16Z","timestamp":1776869356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The MIF-CD74 axis drives colorectal cancer via glycolytic reprogramming and is targeted by a novel small-molecule inhibitor"],"prefix":"10.1007","volume":"49","author":[{"given":"Jinwei","family":"Lou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangshang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"1","key":"1202_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"R.L. Siegel","year":"2025","unstructured":"R.L. Siegel, T.B. Kratzer, A.N. Giaquinto, H. Sung, A. Jemal, Cancer statistics, 2025. CA Cancer J. Clin. 75(1), 10\u201345 (2025). https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clinicians"},{"issue":"3","key":"1202_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/cac2.12639","volume":"45","author":"F. Wang","year":"2025","unstructured":"F. Wang, G. Chen, Z. Zhang, Y. Yuan, Y. Wang, Y.H. Gao, W. Sheng, Z. Wang, X. Li, X. Yuan, S. Cai, L. Ren, Y. Liu, J. Xu, Y. Zhang, H. Liang, X. Wang, A. Zhou, J. Ying, G. Li, M. Cai, G. Ji, T. Li, J. Wang, H. Hu, K. Nan, L. Wang, S. Zhang, J. Li, R.-H. Xu, The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update. Cancer Commun. 45(3), 332\u2013379 (2025). https:\/\/doi.org\/10.1002\/cac2.12639","journal-title":"Cancer Commun."},{"issue":"1","key":"1202_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q. Li","year":"2024","unstructured":"Q. Li, S. Geng, H. Luo, W. Wang, Y.Q. Mo, Q. Luo, L. Wang, G.B. Song, J.P. Sheng, B. Xu, Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Sig Transduct Target Ther. 9(1), 266 (2024). https:\/\/doi.org\/10.1038\/s41392-024-01953-7","journal-title":"Sig Transduct Target Ther."},{"issue":"10207","key":"1202_CR4","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E. Dekker","year":"2019","unstructured":"E. Dekker, P.J. Tanis, J.L.A. Vleugels, P.M. Kasi, M.B. Wallace, Colorectal cancer. Lancet 394(10207), 1467\u20131480 (2019). https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"Lancet"},{"issue":"11","key":"1202_CR5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L. Leng","year":"2003","unstructured":"L. Leng, C.N. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, T. Delohery, Y. Chen, R.A. Mitchell, R. Bucala, MIF Signal transduction initiated by binding to CD74. J. Exp. Med. 197(11), 1467\u20131476 (2003). https:\/\/doi.org\/10.1084\/jem.20030286","journal-title":"J. Exp. Med."},{"issue":"1","key":"1202_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cytogfr.2012.08.001","volume":"24","author":"M.D. Sanchez-Ni\u00f1o","year":"2013","unstructured":"M.D. Sanchez-Ni\u00f1o, A.B. Sanz, O. Ruiz-Andres, J. Poveda, M.C. Izquierdo, R. Selgas, J. Egido, A. Ortiz, MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple. Cytokine Growth Factor Rev. 24(1), 23\u201340 (2013). https:\/\/doi.org\/10.1016\/j.cytogfr.2012.08.001","journal-title":"Cytokine Growth Factor Rev."},{"key":"1202_CR7","doi-asserted-by":"publisher","first-page":"108024","DOI":"10.1016\/j.pharmthera.2021.108024","volume":"233","author":"K. Sumaiya","year":"2022","unstructured":"K. Sumaiya, D. Langford, K. Natarajaseenivasan, S. Shanmughapriya, Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol. Ther. 233, 108024 (2022). https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108024","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"1202_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","volume":"25","author":"X. Shi","year":"2006","unstructured":"X. Shi, L. Leng, T. Wang, W. Wang, X. Du, J. Li, C. McDonald, Z. Chen, J.W. Murphy, E. Lolis, P. Noble, W. Knudson, R. Bucala, CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25(4), 595\u2013606 (2006). https:\/\/doi.org\/10.1016\/j.immuni.2006.08.020","journal-title":"Immunity"},{"issue":"5","key":"1202_CR9","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1074\/jbc.M703265200","volume":"283","author":"Y. Gore","year":"2008","unstructured":"Y. Gore, D. Starlets, N. Maharshak, S. Becker-Herman, U. Kaneyuki, L. Leng, R. Bucala, I. Shachar, Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283(5), 2784\u20132792 (2008). https:\/\/doi.org\/10.1074\/jbc.M703265200","journal-title":"J. Biol. Chem."},{"issue":"1","key":"1202_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cellsig.2010.08.013","volume":"23","author":"H. Lue","year":"2011","unstructured":"H. Lue, M. Dewor, L. Leng, R. Bucala, J. Bernhagen, Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell. Signal. 23(1), 135\u2013144 (2011). https:\/\/doi.org\/10.1016\/j.cellsig.2010.08.013","journal-title":"Cell. Signal."},{"issue":"1\u20132","key":"1202_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2119\/molmed.2008.00107","volume":"15","author":"X.-X. He","year":"2009","unstructured":"X.-X. He, K. Chen, J. Yang, X.-Y. Li, H.-Y. Gan, C.-Y. Liu, T.R. Coleman, Y. Al-Abed, Macrophage migration inhibitory factor promotes colorectal cancer. Mol. Med. 15(1\u20132), 1\u201310 (2009). https:\/\/doi.org\/10.2119\/molmed.2008.00107","journal-title":"Mol. Med."},{"issue":"4","key":"1202_CR12","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1007\/s12013-024-01430-6","volume":"82","author":"S. Hu","year":"2024","unstructured":"S. Hu, J. Feng, W. Fu, Y. Guo, Macrophage migration inhibitory factor (MIF) upregulates CXCR7 and contributes to chemotherapy resistance in colorectal cancer. Cell. Biochem. Biophys. 82(4), 3437\u20133452 (2024). https:\/\/doi.org\/10.1007\/s12013-024-01430-6","journal-title":"Cell. Biochem Biophys."},{"issue":"8","key":"1202_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-23-2390","volume":"84","author":"L. Yan","year":"2024","unstructured":"L. Yan, M. Wu, T. Wang, H. Yuan, X. Zhang, H. Zhang, T. Li, V. Pandey, X. Han, P.E. Lobie, T. Zhu, Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion. Cancer Res. 84(8), 1270\u20131285 (2024). https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2390","journal-title":"Cancer Res."},{"issue":"4","key":"1202_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.cmet.2025.01.018","volume":"37","author":"Q. Cui","year":"2025","unstructured":"Q. Cui, S. Li, X. Liu, J. Liu, W. Chen, Y. Sheng, P. Xie, L. Jin, F. Zeng, F. Lv, X. Hu, R.-P. Xiao, MIF-ACKR3 causes irreversible fat loss by impairing adipogenesis in cancer cachexia. Cell. Metab. 37(4), 954\u2013970.e8 (2025). https:\/\/doi.org\/10.1016\/j.cmet.2025.01.018","journal-title":"Cell. Metab."},{"key":"1202_CR15","doi-asserted-by":"publisher","unstructured":"P.V. Tilstam, W. Schulte, T. Holowka, B.S. Kim, J. Nouws, M. Sauler, M. Piecychna, G. Pantouris, E. Lolis, L. Leng, J. Bernhagen, G. Fingerle-Rowson, R. Bucala, MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model. J. Clin. Investigation 131(23 2021). https:\/\/doi.org\/10.1172\/JCI127171","DOI":"10.1172\/JCI127171"},{"issue":"1","key":"1202_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12016-019-08726-z","volume":"58","author":"M.T. Bozza","year":"2020","unstructured":"M.T. Bozza, L. Lintomen, J.Z. Kitoko, C.N. Paiva, P.C. Olsen, The role of MIF on eosinophil biology and eosinophilic inflammation. Clinic Rev Allerg Immunol. 58(1), 15\u201324 (2020). https:\/\/doi.org\/10.1007\/s12016-019-08726-z","journal-title":"Clinic Rev Allerg Immunol."},{"issue":"22","key":"1202_CR17","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood.2020005795","volume":"136","author":"Q. Wang","year":"2020","unstructured":"Q. Wang, D. Zhao, M. Xian, Z. Wang, E. Bi, P. Su, J. Qian, X. Ma, M. Yang, L. Liu, Y. Zu, S.R. Pingali, K. Chen, Z. Cai, Q. Yi, MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma. Blood 136(22), 2557\u20132573 (2020). https:\/\/doi.org\/10.1182\/blood.2020005795","journal-title":"Blood"},{"issue":"3","key":"1202_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/med.21385","volume":"36","author":"C. O\u2019Reilly","year":"2016","unstructured":"C. O\u2019Reilly, M. Doroudian, L. Mawhinney, S.C. Donnelly, Targeting MIF in cancer: therapeutic strategies, current developments, and Future opportunities. Med Res Rev. 36(3), 440\u2013460 (2016). https:\/\/doi.org\/10.1002\/med.21385","journal-title":"Med Res Rev."},{"issue":"1","key":"1202_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4155\/fmc.10.281","volume":"3","author":"Y. Al-Abed","year":"2011","unstructured":"Y. Al-Abed, S. VanPatten, MIF as a disease target: ISO-1 as a proof-of-concept therapeutic. Future medicinal chemistry. Future Med Chem. 3(1), 45\u201363 (2011). https:\/\/doi.org\/10.4155\/fmc.10.281","journal-title":"Future Med Chem."},{"key":"1202_CR20","doi-asserted-by":"publisher","unstructured":"J. Jarmula, J. Lee, A. Lauko, P. Rajappa, M.M. Grabowski, A. Dhawan, P. Chen, R. Bucala, M.A. Vogelbaum, J.D. Lathia, Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: a review. Neuro-Oncol. Adv. 6(1 2024). https:\/\/doi.org\/10.1093\/noajnl\/vdae142","DOI":"10.1093\/noajnl\/vdae142"},{"key":"1202_CR21","doi-asserted-by":"publisher","unstructured":"L. Putha, L.K. Kok, M. Fellner, M.T. Rutledge, A.B. Gamble, S.M. Wilbanks, A.J. Vernall, J.D.A. Tyndall, Covalent isothiocyanate inhibitors of Macrophage migration inhibitory factor as potential colorectal cancer treatments. ChemMedchem 19(21 2024). https:\/\/doi.org\/10.1002\/cmdc.202400394","DOI":"10.1002\/cmdc.202400394"},{"issue":"5","key":"1202_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"W.H. Koppenol","year":"2011","unstructured":"W.H. Koppenol, P.L. Bounds, C.V. Dang, Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer. 11(5), 325\u2013337 (2011). https:\/\/doi.org\/10.1038\/nrc3038","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1202_CR23","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F. Fontana","year":"2024","unstructured":"F. Fontana, G. Giannitti, S. Marchesi, P. Limonta, The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int. J. Biol. Sci. 20(8), 3113\u20133125 (2024). https:\/\/doi.org\/10.7150\/ijbs.89942","journal-title":"Int. J. Biol. Sci."},{"key":"1202_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P. Icard","year":"2018","unstructured":"P. Icard, S. Shulman, D. Farhat, J.M. Steyaert, M. Alifano, H. Lincet, How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. Drug. Resist. Updat. 38, 1\u201311 (2018). https:\/\/doi.org\/10.1016\/j.drup.2018.03.001","journal-title":"Drug. Resist. Updat."},{"issue":"1","key":"1202_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","volume":"17","author":"Z. Wang","year":"2020","unstructured":"Z. Wang, Q. Jiang, C. Dong, Metabolic reprogramming in triple-negative breast cancer. Cancer Biol. Med. 17(1), 44\u201359 (2020). https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0210","journal-title":"Cancer Biol. Med."},{"issue":"13","key":"1202_CR26","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/0008-5472.CAN-24-1304","volume":"84","author":"J.A. Enr\u00edquez","year":"2024","unstructured":"J.A. Enr\u00edquez, M. Mittelbrunn, Mittelbrunn M: Warburg effect reshapes tumor immunogenicity. Cancer Res. 84(13), 2043\u20132045 (2024). https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-1304","journal-title":"Cancer Res."},{"issue":"15","key":"1202_CR27","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"S.M. Fendt","year":"2024","unstructured":"S.M. Fendt, 100 years of the Warburg effect: a cancer metabolism endeavor. Cell 187(15), 3824\u20133828 (2024). https:\/\/doi.org\/10.1016\/j.cell.2024.06.026","journal-title":"Cell"},{"issue":"9","key":"1202_CR28","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1021\/jm401908w","volume":"57","author":"L. Xu","year":"2014","unstructured":"L. Xu, Y. Zhang, L. Zheng, C. Qiao, Y. Li, D. Li, X. Zhen, T. Hou, Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays. J. Med. Chem. 57(9), 3737\u20133745 (2014). https:\/\/doi.org\/10.1021\/jm401908w","journal-title":"J. Med. Chem."},{"issue":"7","key":"1202_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","volume":"15","author":"I. Kang","year":"2019","unstructured":"I. Kang, R. Bucala, The immunobiology of MIF: function, genetics and prospects for precision medicine. Nat. Rev. Rheumatol. 15(7), 427\u2013437 (2019). https:\/\/doi.org\/10.1038\/s41584-019-0238-2","journal-title":"Nat. Rev. Rheumatol."},{"key":"1202_CR30","doi-asserted-by":"publisher","first-page":"100797","DOI":"10.1016\/j.drup.2021.100797","volume":"59","author":"A.C. Gon\u00e7alves","year":"2021","unstructured":"A.C. Gon\u00e7alves, E. Richiardone, J. Jorge, B. Pol\u00f3nia, C.P.R. Xavier, I.C. Salaroglio, C. Riganti, M.H. Vasconcelos, C. Corbet, A.B. Sarmento-Ribeiro, Impact of cancer metabolism on therapy resistance \u2013 clinical implications. Drug. Resist Updat. 59, 100797 (2021). https:\/\/doi.org\/10.1016\/j.drup.2021.100797","journal-title":"Drug. Resist Updat."},{"issue":"3","key":"1202_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"N.N. Pavlova","year":"2022","unstructured":"N.N. Pavlova, J. Zhu, C.B. Thompson, The hallmarks of cancer metabolism: still emerging. Cell. Metab. 34(3), 355\u2013377 (2022). https:\/\/doi.org\/10.1016\/j.cmet.2022.01.007","journal-title":"Cell. Metab."},{"issue":"1","key":"1202_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J. Feng","year":"2020","unstructured":"J. Feng, J. Li, L. Wu, Q. Yu, J. Ji, J. Wu, W. Dai, C. Guo, Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 39(1), 126 (2020). https:\/\/doi.org\/10.1186\/s13046-020-01629-4","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8021","key":"1202_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H. Chen","year":"2024","unstructured":"H. Chen, Y. Li, H. Li, X. Chen, H. Fu, D. Mao, W. Chen, L. Lan, C. Wang, K. Hu, J. Li, C. Zhu, I. Evans, E. Cheung, D. Lu, Y. He, A. Behrens, D. Yin, C. Zhang, NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631(8021), 663\u2013669 (2024). https:\/\/doi.org\/10.1038\/s41586-024-07620-9","journal-title":"Nature"},{"issue":"1","key":"1202_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s10020-025-01205-6","volume":"31","author":"W. Zhang","year":"2025","unstructured":"W. Zhang, M. Xia, J. Li, G. Liu, Y. Sun, X. Chen, J. Zhong, Warburg effect and lactylation in cancer: mechanisms for chemoresistance. Mol. Med. 31(1), 146 (2025). https:\/\/doi.org\/10.1186\/s10020-025-01205-6","journal-title":"Mol. Med."},{"key":"1202_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cytogfr.2023.05.001","volume":"73","author":"B. Pol\u00f3nia","year":"2023","unstructured":"B. Pol\u00f3nia, C.P.R. Xavier, J. Kopecka, C. Riganti, M.H. Vasconcelos, The role of extracellular vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: consequences for drug resistance. Cytokine Growth Factor Rev. 73, 150\u2013162 (2023). https:\/\/doi.org\/10.1016\/j.cytogfr.2023.05.001","journal-title":"Cytokine Growth Factor Rev."},{"issue":"16","key":"1202_CR36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"E. Lionta","year":"2014","unstructured":"E. Lionta, G. Spyrou, D.K. Vassilatis, Z. Cournia, Cournia Z: structure-based virtual screening for drug discovery: principles, applications and recent advances. CTMC 14(16), 1923\u20131938 (2014). https:\/\/doi.org\/10.2174\/1568026614666140929124445","journal-title":"CTMC"},{"issue":"6","key":"1202_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"H.O. Lee","year":"2020","unstructured":"H.O. Lee, Y. Hong, H.E. Etlioglu, Y.B. Cho, V. Pomella, B. Van den Bosch, J. Vanhecke, S. Verbandt, H. Hong, J.W. Min, N. Kim, H.H. Eum, J. Qian, B. Boeckx, D. Lambrechts, P. Tsantoulis, G. De Hertogh, W. Chung, T. Lee, M. An, H.-T. Shin, J.-G. Joung, M.-H. Jung, G. Ko, P. Wirapati, S.H. Kim, H.C. Kim, S.H. Yun, I.B.H. Tan, B. Ranjan, W.Y. Lee, T.-Y. Kim, J.K. Choi, Y.-J. Kim, S. Prabhakar, S. Tejpar, W.-Y. Park, Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat. Genet. 52(6), 594\u2013603 (2020). https:\/\/doi.org\/10.1038\/s41588-020-0636-z","journal-title":"Nat. Genet."},{"key":"1202_CR38","doi-asserted-by":"publisher","unstructured":"F. Uhlitz, P. Bischoff, S. Peidli, A. Sieber, A. Trinks, M. L\u00fcthen, B. Obermayer, E. Blanc, Y. Ruchiy, T. Sell, S. Mamlouk, R. Arsie, T.-T. Wei, K. Klotz-Noack, R.F. Schwarz, B. Sawitzki, C. Kamphues, D. Beule, M. Landthaler, C. Sers, D. Horst, N. Bl\u00fcthgen, M. Morkel, Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer. EMBO Mol Med. 13(10), e14123 (2021). https:\/\/doi.org\/10.15252\/emmm.202114123","DOI":"10.15252\/emmm.202114123"},{"issue":"12","key":"1202_CR39","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I. Korsunsky","year":"2019","unstructured":"I. Korsunsky, N. Millard, J. Fan, K. Slowikowski, F. Zhang, K. Wei, Y. Baglaenko, M. Brenner, P.R. Loh, S. Raychaudhuri, Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16(12), 1289\u20131296 (2019). https:\/\/doi.org\/10.1038\/s41592-019-0619-0","journal-title":"Nat Methods"},{"key":"1202_CR40","doi-asserted-by":"publisher","unstructured":"M.S. Chen, Y.H. Lo, X. Chen, C.S. Williams, J.M. Donnelly, Criss ZK, 2nd, Z.K. Criss, S. Patel, J. Butkus, M.J. Dubrulle, M.J. Finegold, N.F. Shroyer, Growth factor\u2013independent 1 is a tumor suppressor gene in colorectal cancer. Mol. Cancer Res. 17(3), 697\u2013708 (2019). https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0666","DOI":"10.1158\/1541-7786.MCR-18-0666"},{"issue":"2","key":"1202_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D. Aran","year":"2019","unstructured":"D. Aran, A.P. Looney, L. Liu, E. Wu, V. Fong, A. Hsu, S. Chak, R.P. Naikawadi, P.J. Wolters, A.R. Abate, A.J. Butte, M. Bhattacharya, Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20(2), 163\u2013172 (2019). https:\/\/doi.org\/10.1038\/s41590-018-0276-y","journal-title":"Nat. Immunol."},{"key":"1202_CR42","doi-asserted-by":"publisher","unstructured":"C. Hu, T. Li, Y. Xu, X. Zhang, F. Li, J. Bai, J. Chen, W. Jiang, K. Yang, Q. Ou, X. Li, P. Wang, Y. Zhang, CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 51(D1), D870\u2013d876 (2023). https:\/\/doi.org\/10.1093\/nar\/gkac947","DOI":"10.1093\/nar\/gkac947"},{"issue":"1","key":"1202_CR43","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S. Jin","year":"2021","unstructured":"S. Jin, C.F. Guerrero-Juarez, L. Zhang, I. Chang, R. Ramos, C.H. Kuan, P. Myung, M.V. Plikus, Q. Nie, Inference and analysis of cell-cell communication using CellChat. Nat Commun. 12(1), 1088 (2021). https:\/\/doi.org\/10.1038\/s41467-021-21246-9","journal-title":"Nat Commun."},{"issue":"5930","key":"1202_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"M.G. Vander Heiden","year":"2009","unstructured":"M.G. Vander Heiden, L.C. Cantley, C.B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation. Sci. (New Y., NY) 324(5930), 1029\u20131033 (2009). https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Sci. (New Y., NY)"},{"issue":"2","key":"1202_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/jm801100v","volume":"52","author":"Z. Cournia","year":"2009","unstructured":"Z. Cournia, L. Leng, S. Gandavadi, X. Du, R. Bucala, W.L. Jorgensen, Discovery of human Macrophage migration inhibitory factor (MIF)-CD74 Antagonists via virtual screening. J. Med. Chem. 52(2), 416\u2013424 (2009). https:\/\/doi.org\/10.1021\/jm801100v","journal-title":"J. Med. Chem."},{"issue":"6","key":"1202_CR46","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41401-021-00753-x","volume":"43","author":"Y. Zhang","year":"2022","unstructured":"Y. Zhang, L. Xu, Y. Zhang, J. Pan, P.-Q. Wang, S. Tian, H.-T. Li, B.-W. Gao, T.-J. Hou, X.-C. Zhen, L.-T. Zheng, Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays. Acta. Pharmacol. Sin. 43(6), 1508\u20131520 (2022). https:\/\/doi.org\/10.1038\/s41401-021-00753-x","journal-title":"Acta Pharmacol Sin."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01202-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01202-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01202-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:49:17Z","timestamp":1776869357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01202-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1202"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01202-9","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in compliance with the ethical standards outlined in the Declaration of Helsinki. The studies involving human participants were reviewed and approved by the Ethics Committees and Institutional Review Boards of Nanjing First Hospital, affiliated with Nanjing Medical University. The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}